Space stocks ranked by market cap:
$SATL ~ 721.02 Million
$BKSY ~ 1.03 Billion
$VOYG ~ 1.67 Billion
$RDW ~ 1.82 Billion
$LUNR ~ 4.44 Billion
$PL ~ 11.79 Billion
$ASTS ~ 33.96 Billion
$RKLB ~ 39.07 Billion
SpaceX IPO ~ $1.75 Trillion
I think this valuation gap will deliver insane returns in the next few months.
$SATL ~ 721.02 Million
$BKSY ~ 1.03 Billion
$VOYG ~ 1.67 Billion
$RDW ~ 1.82 Billion
$LUNR ~ 4.44 Billion
$PL ~ 11.79 Billion
$ASTS ~ 33.96 Billion
$RKLB ~ 39.07 Billion
SpaceX IPO ~ $1.75 Trillion
I think this valuation gap will deliver insane returns in the next few months.
✍1
🇨🇭 Global One SI - Prompt
$SPIR/USD H2 #Indicator #Signal #Trading #GlobalOneAI
$SPIR: Spire strengthening it's ability to deliver RF intelligence, supporting defense and national security missions worldwide.
Spire has successfully demonstrated single-satellite radio frequency (RF) geolocation techniques on orbit, including the detection and geolocation of S-band and X-band radio frequency signals.
Spire’s single-satellite RF geolocation capability expands the company’s RF sensing capabilities by enabling the identification and geolocation of higher-frequency emitters, including S- and X-band signals, using sensors onboard a single satellite.
Spire has successfully demonstrated single-satellite radio frequency (RF) geolocation techniques on orbit, including the detection and geolocation of S-band and X-band radio frequency signals.
Spire’s single-satellite RF geolocation capability expands the company’s RF sensing capabilities by enabling the identification and geolocation of higher-frequency emitters, including S- and X-band signals, using sensors onboard a single satellite.
Amazon aims to deliver broadband commercial service in just months, targeting underserved latitudes first and expanding rapidly.
At Sat Show 2026, Amazon Leo VP of Business Chris Weber described the schedule as "very aggressive," with commercial service expected within months.
The company plans to roughly double the pace over the next year, with more than 100 additional launches secured across multiple providers including SpaceX, United Launch Alliance, Arianespace, and Blue Origin.
At Sat Show 2026, Amazon Leo VP of Business Chris Weber described the schedule as "very aggressive," with commercial service expected within months.
The company plans to roughly double the pace over the next year, with more than 100 additional launches secured across multiple providers including SpaceX, United Launch Alliance, Arianespace, and Blue Origin.
👀1
Tuesday, Mar 24 2026, 12:00 UTC time
📋 Market Movers — Geopolitical Risk & Oil
✅ Oil jumps ~4% as Iran denies US talks; Brent threats to $150 lift risk premia. Global markets wobble on Iran tensions — equities volatile, safe-haven flows lift Treasuries and dollar intermittently while oil-linked currencies and energy shares swing.
🔖 US & Rates
📌 Dow +600 on relief after Trump delays Iran strikes; US 10Y yield climbs as Middle East uncertainty lingers. Treasury yields drift higher amid risk repricing; dollar direction mixed — bouts of safe-haven demand but also profit-taking on risk rallies.
📋 Europe — PMIs, Yields & Growth
✅ Eurozone business activity weakest in 10 months; services nearly stall — euro falls below $1.16. Germany posts mixed PMI (manufacturing strong, services weaker). French private sector contracts; French manufacturing surprising >50. Bund yields ease to ~3% on risk-off, euro soft.
🔖 UK — Growth Pain & Housing Strains
📌 UK PMIs at 6‑month lows; retail sales plunge; mortgage market disrupted by Iran war. Sterling weaker, gilts yields soften slightly (gilt yield ~4.85% cited). Homebuilders and lenders warn on margins and sector risks.
📋 Canada
✅ Bank of Canada to lose two Governing Council members; small business confidence plunges. Domestic sentiment hit; policy continuity watch-worthy for CAD and BoC guidance.
🔖 Asia & Pacific — PMIs, RBNZ & Australia
📌 RBNZ signals further hikes possible if inflation persists; NZD weakens. Australia faces contraction signals across private sector, services, factory PMIs; consumer confidence at record lows and stocks volatile. South Korea currency pressured; Asian PMIs point to Mideast conflict spillovers.
📋 China & Japan
✅ China 10Y yield edges down amid risk shifts; flash PMIs show regional weakness tied to Middle East tensions. Focus on policy cues and growth momentum as spillovers hit trade-linked Asia.
🔖 EU–Australia Deal & Trade
📌 EU and Australia sign free-trade and security agreement. Positive long-term trade implication for Europe-Pacific linkage; markets focus remains on near-term geo-risk.
📋 Commodities & FXflow
✅ Gold under pressure with ETF outflows; dollar alternates between weakness and bids; oil biggest near-term market driver. Oil-led inflation concerns raise odds of sticky global inflation — central bank sensitivity increases.
🔖 Other notable items
📌 Brazil central bank flags data-dependent rate path; Switzerland current account surplus narrows; Canada retailer Dollarama warns on sales. Global divergence in policy and growth narratives persists — watch data and geopolitical headlines for next moves.
📋 Market Movers — Geopolitical Risk & Oil
✅ Oil jumps ~4% as Iran denies US talks; Brent threats to $150 lift risk premia. Global markets wobble on Iran tensions — equities volatile, safe-haven flows lift Treasuries and dollar intermittently while oil-linked currencies and energy shares swing.
🔖 US & Rates
📌 Dow +600 on relief after Trump delays Iran strikes; US 10Y yield climbs as Middle East uncertainty lingers. Treasury yields drift higher amid risk repricing; dollar direction mixed — bouts of safe-haven demand but also profit-taking on risk rallies.
📋 Europe — PMIs, Yields & Growth
✅ Eurozone business activity weakest in 10 months; services nearly stall — euro falls below $1.16. Germany posts mixed PMI (manufacturing strong, services weaker). French private sector contracts; French manufacturing surprising >50. Bund yields ease to ~3% on risk-off, euro soft.
🔖 UK — Growth Pain & Housing Strains
📌 UK PMIs at 6‑month lows; retail sales plunge; mortgage market disrupted by Iran war. Sterling weaker, gilts yields soften slightly (gilt yield ~4.85% cited). Homebuilders and lenders warn on margins and sector risks.
📋 Canada
✅ Bank of Canada to lose two Governing Council members; small business confidence plunges. Domestic sentiment hit; policy continuity watch-worthy for CAD and BoC guidance.
🔖 Asia & Pacific — PMIs, RBNZ & Australia
📌 RBNZ signals further hikes possible if inflation persists; NZD weakens. Australia faces contraction signals across private sector, services, factory PMIs; consumer confidence at record lows and stocks volatile. South Korea currency pressured; Asian PMIs point to Mideast conflict spillovers.
📋 China & Japan
✅ China 10Y yield edges down amid risk shifts; flash PMIs show regional weakness tied to Middle East tensions. Focus on policy cues and growth momentum as spillovers hit trade-linked Asia.
🔖 EU–Australia Deal & Trade
📌 EU and Australia sign free-trade and security agreement. Positive long-term trade implication for Europe-Pacific linkage; markets focus remains on near-term geo-risk.
📋 Commodities & FXflow
✅ Gold under pressure with ETF outflows; dollar alternates between weakness and bids; oil biggest near-term market driver. Oil-led inflation concerns raise odds of sticky global inflation — central bank sensitivity increases.
🔖 Other notable items
📌 Brazil central bank flags data-dependent rate path; Switzerland current account surplus narrows; Canada retailer Dollarama warns on sales. Global divergence in policy and growth narratives persists — watch data and geopolitical headlines for next moves.
Key focus for traders: monitor oil, US yields, EUR/USD, GBP/JPY, AUD/NZD for risk tone; central bank communications (RBNZ, BoC, Brazil) and regional PMIs for directional cues.
🇨🇭 Global One SI - Prompt
$IBRX/USD H2 #Indicator #Signal #Trading #GlobalOneAI
$IBRX - Anktiva Takes the Next Giant Leap 🔥
ImmunityBio’s Anktiva just entered the pre-surgery (neoadjuvant) pancreatic cancer combo trial with a Bristol Myers Squibb drug.
This is no small milestone - this is a monster move:
- Strong Big-Pharma validation from BMS
- Targeting one of the deadliest cancers with enormous unmet need
- Perfectly aligns with the platform strategy: Anktiva as the “turbo” for vaccines, checkpoint inhibitors & chemo
- Neoadjuvant trials deliver fast efficacy signals (pathologic response)
After the bladder-cancer success, this is the jump into solid tumors.
If the data hits, Anktiva becomes a true platform immunotherapy.
$IBRX is still massively undervalued 📈
ImmunityBio’s Anktiva just entered the pre-surgery (neoadjuvant) pancreatic cancer combo trial with a Bristol Myers Squibb drug.
This is no small milestone - this is a monster move:
- Strong Big-Pharma validation from BMS
- Targeting one of the deadliest cancers with enormous unmet need
- Perfectly aligns with the platform strategy: Anktiva as the “turbo” for vaccines, checkpoint inhibitors & chemo
- Neoadjuvant trials deliver fast efficacy signals (pathologic response)
After the bladder-cancer success, this is the jump into solid tumors.
If the data hits, Anktiva becomes a true platform immunotherapy.
$IBRX is still massively undervalued 📈
🇨🇭 Global One SI - Prompt
$ONDS/USD H2 #Indicator #Signal #Trading #GlobalOneAI
Needham raises its price target for Ondas $ONDS to $23, with the rating now Under Review.
Analyst Austin Bohlig cites an aggressive M&A strategy and a $500M pipeline, seeing a clear path toward $375M to $500M in 2026 revenue.
Analyst Austin Bohlig cites an aggressive M&A strategy and a $500M pipeline, seeing a clear path toward $375M to $500M in 2026 revenue.